Physician profile
Amy O Johnson
NPI 1003811985
$969.80
in general payments reported to CMS, 2019-2025
12 companies · $28.58 in 2025
The $28.58 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2021: $212 · 2022: $165 · 2023: $82.23 · 2024: $237 · 2025: $28.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $396.19 | 2021-2024 | Signia, Endoflip |
| Intuitive Surgical, INC. | $196.64 | 2019 | |
| Abbvie INC. | $70.47 | 2021 | |
| Daiichi Sankyo INC. | $70.38 | 2022-2024 | Injectafer |
| La Jolla Pharmaceutical Company | $54.40 | 2021-2022 | |
| Ethicon US, LLC | $48.66 | 2019 | |
| Nestle Healthcare Nutrition INC. | $29.57 | 2021 | |
| Janssen Biotech, INC. | $28.58 | 2025 | Tremfya |
| Polynovo North America LLC | $28.29 | 2024 | Novosorb Btm |
| Eagle Pharmaceuticals, INC. | $16.83 | 2023 | |
| Tela Bio, INC. | $15.85 | 2021 | |
| Meditrina | $13.94 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.